SmallCap
CompaniesMapStatistics

(주)디앤디파마텍

Venture Certified
Data Quality: 95/10

Basic Information


Unlisted

Company Name(주)디앤디파마텍
English NameD&D Pharmatech Inc.
Business Reg. No.1208821933
CEO이슬기
Address경기도 성남시 수정구 금토로80번길 27 (금토동, 텔레칩스) 4층
Industry의학 및 약학 연구개발업
Industry Code70113
EstablishedContact
Phone031-8019-7771
Websitewww.ddpharmatech.com
Regular Employees26persons
Corp. Reg. No.1101115575662

Investment Metrics


Market Cap
-
Op. Margin
-121.61%
ROE
-6.2%
Debt Ratio
4.94%

Certification Status


Venture Certified

Cert. History
벤처투자유형2018-08-09 ~ 2020-08-08201803005572018-08-09
벤처투자유형2020-08-09 ~ 2022-08-08202003008572018-08-09
벤처투자유형2022-08-09 ~ 2025-08-08202208030100092018-08-09
벤처투자유형2025-08-09 ~ 2028-08-08202508120100102018-08-09

Financial Statements


3-Year Financial Data

Revenue CAGR +303.3%

Item202420232022
Revenue

84B

161B

5.2B

Operating Profit

-102B

33B

-158B

Net Profit

-75B

111B

-2,402B

Total Assets

1,269B

950B

980B

Total Liabilities

60B

51B

493B

Total Equity

1,209B

899B

487B

Risk Indicators


2 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
84B

0.8%

vs. 3-Year Avg.: 83B
Operating Profit
-102B

62.9%

vs. 3-Year Avg.: -63B
Op. Margin
-121.6%

92.0%

vs. 3-Year Avg.: -1524.1%
Debt Ratio
4.9%

90.8%

vs. 3-Year Avg.: 53.5%
ROE
-6.2%

97.4%

vs. 3-Year Avg.: -240.6%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
이슬기대표이사대표

Employment Status


NPS Subscribers

26persons

CEO이슬기
Est. Avg. Annual Salary

6,35510K

(53010K/mo)
Based on NPS rate 9.5%
Hired (12 mo)

+1persons

Left (12 mo)

-0persons

Net Change (12 mo)

+1persons

NPS Join Date

2014-12-05

Monthly Employee Trend
Hired
Left

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


2 Additional Data Sources

{
  "address": "경기도 성남시 수정구 금토로80번길",
  "brno": "120882****",
  "cappedWarning": false,
  "companyName": "(주)디앤디파마텍",
  "estimatedAvgAnnualSalary": 63545388,
  "estimatedAvgMonthlySalary": 5295449,
  "fetchedAt": "2026-03-05T19:57:46.106Z",
  "industryCode": "730000",
  "industryName": "기타 인문 및 사회과학 연구개발업",
  "joinDate": "20141205",
  "last12MonthsHired": 1,
  "last12MonthsLeft": 0,
  "last12MonthsNetChange": 1,
  "leaveDate": null,
  "monthlyPensionAmount": 13079760,
  "monthlyTrend": [
    {
      "lostSubscribers": 0,
      "newSubscribers": 1,
      "yearMonth": null
    }
  ],
  "npsRateUsed": 0.095,
  "npsUpperCap": 6370000,
  "seq": "6750804",
  "status": "1",
  "styleCode": "1",
  "subscriberCount": 26,
  "turnoverMonths": 1
}

{
  "address": "경기 성남시",
  "ceo_name": "이슬기",
  "certificate": [
    {
      "cert_number": "20180300557",
      "changes": "",
      "disclosure_date": "2018-08-09",
      "first_cert_date": "2018-08-09",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2018-08-09 ~ 2020-08-08"
    },
    {
      "cert_number": "20200300857",
      "changes": "",
      "disclosure_date": "2020-07-30",
      "first_cert_date": "2018-08-09",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2020-08-09 ~ 2022-08-08"
    },
    {
      "cert_number": "20220803010009",
      "changes": "",
      "disclosure_date": "2022-08-03",
      "first_cert_date": "2018-08-09",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2022-08-09 ~ 2025-08-08"
    },
    {
      "cert_number": "20250812010010",
      "changes": "",
      "disclosure_date": "2025-08-12",
      "first_cert_date": "2018-08-09",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2025-08-09 ~ 2028-08-08"
    }
  ],
  "company_name": "(주)디앤디파마텍",
  "financials": {
    "2022": {
      "capital_stock": 4033584000,
      "cost_of_sales": 0,
      "current_assets": 20105439000,
      "current_liabilities": 46470740000,
      "gross_profit": 515108000,
      "net_income": -240167339000,
      "net_income_bs": -240167338000,
      "non_current_assets": 77880148000,
      "non_current_liabilities": 2848746000,
      "non_operating_expenses": 240422287000,
      "non_operating_income": 16061292000,
      "operating_profit": -15806344000,
      "revenue": 515108000,
      "sga_expenses": 16321451000,
      "total_assets": 97985587000,
      "total_equity": 48666101000,
      "total_liabilities": 49319486000
    },
    "2023": {
      "capital_stock": 4649465000,
      "cost_of_sales": 0,
      "current_assets": 16091725000,
      "current_liabilities": 3204501000,
      "gross_profit": 16112110000,
      "net_income": 11063901000,
      "net_income_bs": 9150052000,
      "non_current_assets": 78956105000,
      "non_current_liabilities": 1941469000,
      "non_operating_expenses": 9063482000,
      "non_operating_income": 16834665000,
      "operating_profit": 3292718000,
      "revenue": 16112110000,
      "sga_expenses": 12819391000,
      "total_assets": 95047829000,
      "total_equity": 89901859000,
      "total_liabilities": 5145970000
    },
    "2024": {
      "capital_stock": 5284035000,
      "cost_of_sales": 0,
      "current_assets": 34011665000,
      "current_liabilities": 2631222000,
      "gross_profit": 8378922000,
      "net_income": -7491205000,
      "net_income_bs": -7501363000,
      "non_current_assets": 92854496000,
      "non_current_liabilities": 3340023000,
      "non_operating_expenses": 885175000,
      "non_operating_income": 3583409000,
      "operating_profit": -10189439000,
      "revenue": 8378922000,
      "sga_expenses": 18568361000,
      "total_assets": 126866161000,
      "total_equity": 120894916000,
      "total_liabilities": 5971245000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "2,999,000,000",
      "changes": "2,999,000,000",
      "date": "2021-05-07"
    },
    {
      "amount": "1,000,000,000",
      "changes": "1,000,000,000",
      "date": "2021-05-07"
    },
    {
      "amount": "2,999,000,000",
      "changes": "2,999,000,000",
      "date": "2021-05-07"
    },
    {
      "amount": "4,925,705,708",
      "changes": "4,925,705,708",
      "date": "2019-05-17"
    },
    {
      "amount": "3,003,524,062",
      "changes": "3,003,524,062",
      "date": "2019-05-17"
    },
    {
      "amount": "720,800,388",
      "changes": "720,800,388",
      "date": "2019-05-17"
    },
    {
      "amount": "720,800,388",
      "changes": "720,800,388",
      "date": "2019-05-17"
    },
    {
      "amount": "12,500,000,000",
      "changes": "12,500,000,000",
      "date": "2019-05-07"
    },
    {
      "amount": "20,499,000,000",
      "changes": "20,499,000,000",
      "date": "2019-05-07"
    },
    {
      "amount": "2,999,000,000",
      "changes": "2,999,000,000",
      "date": "2018-03-12"
    },
    {
      "amount": "45,999,817,000",
      "changes": "45,999,817,000",
      "date": "2018-03-12"
    },
    {
      "amount": "2,999,000,000",
      "changes": "2,999,000,000",
      "date": "2018-03-12"
    }
  ],
  "phone": "031-8019-****",
  "source": "pg_migration"
}

Data Sources


Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8

Data Sources by Section
SectionSource:Status
Basic InfoDART
Collected
Financial StatementsVenture System
Collected
Investment MetricsVenture System
Collected
OfficersDART
Collected
EmploymentPublic Data
Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
nps2026-03-05
Collected
Venture System Detail2026-03-05
Collected
DART Financial2026-02-26
Collected
G2B Procurement2026-02-25
Collected
Employment Insurance2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Cert. Info2026-02-25
Collected